Early estimates of in-hospital deaths related to hydroxychloroquine treatment for COVID-19 now available. Researchers from France and Canada have estimated there were 16,990 hydroxychloroquine-related deaths during the first wave of the COVID-19 pandemic in six countries for which relevant data were available: Belgium, Turkey, France, Italy, Spain, and the USA. [Pradelle A and others. Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: An estimate. Biomedicine & Pharmacotherapy, 171:116055, Feb 2024] The estimate is based on a calculation that considered: (a) cohort study data to provide estimates of mortality rates and the proportion of hydroxychloroquine exposure; (b) hospitalization data from each country; and (c) data from a meta-analysis of randomized controlled trials indicating 11% greater odds of COVID-19 patients dying when given hydroxychloroquine. The researchers also noted that hydroxychloroquine, a drug used to treat malaria and autoimmune rheumatic diseases, was used off-label early in the pandemic to treat COVID-19 despite only low-level clinical evidence of benefit. Studies have since documented an unfavorable risk-benefit balance, especially due to increased heart-related mortality. (Source: National Council Against Health Fraud Archive)
And I repeat: ". . . a meta-analysis of randomized controlled trials indicating 11% greater odds of COVID-19 patients dying when given hydroxychloroquine."
Donald Trump is still recommending this treatment, no? I guess there is no fraud too small that he won't engage in it, even when he isn't making any money (directly) from it. His motivation is apparently to undermine the "guvmint," using this as evidence that "you can't trust the guvmint."
And one cannot but notice that Trump only got the finest treatment for the disease that can be had (paid for by government insurance) and didn't take his own nostrums (hydroxychloroquine or bleach).
No comments:
Post a Comment